Machine generated contents note: Part One.Gastrointestinal Disorders.(John McDonald, Brian Feagan and Brian Fenerty).1 Gastroesophageal reflux disease.2 Barett's esophagus.3 Esophageal motility disorders: achalasia and spastic motor disorders.4 Esinophilic esophagitis.5 Ulcer disease and helicobacter pylori.6 Non-steroidal anti-inflammatory drug-induced gastroduodenal and enteric toxicity.7 Non-variceal gastrointestinal hemorrhage.8 Functional dyspepsia.9 Celiac disease.10 Crohn's disease.11 Ulcerative colitis.12 Pouchitis after restorative proctocolectomy.13 Microscopic colitis: collagenous and lymphocytic colitis.14 Drug induced Diarreha.15 Metabolic bone disease in gastrointestinal disorders.16 Colorectal cancer in ulcerative colitis: surveillance.17 Colorectal cancer: population screening and surveillance.18 Prevention and treatment of travellers' diarrhoea.19 Clostridium difficile disease.20 Irritable bowel syndrome.21 Ogilvie's syndrome.22 Gallstone disease.23 Acute pancreatitis.24 Obesity.
Text of Note
Part Two Liver disease (Andrew Burroughs).25 Hepatitis C.26 Hepatitis B.27 Alcoholic liver disease.28 Non-alcoholic fatty liver disease.29 Hemochromatosis.30 Wilson disease.31 Primary biliary cirrhosis.32 Autoimmune hepatitis.33 Primary sclerosing cholangitis.34 Non histological assessment of hepatic fibrosis.35 Portal hypertensive bleeding.36 Hepatic outflow syndromes and splanchnic venous thrombosis.37 Ascites, hepatorenal syndrome and spontaneous bacterial peritonitis.38 Hepatic encephalopathy.39 Hepatocellular carcinoma.40 Acute liver failure.41 Liver transplantation: prevention and treatment of rejection.42 Liver transplantation: prevention and treatment of infection.43 Management of HCV infection and liver transplantation.44 Management of HBV infection and liver transplantation.45 Liver biopsy.46 Drug induced liver disease - mechanisms and diagnosis.Index.
8
8
SUMMARY OR ABSTRACT
Text of Note
"This major textbook critically appraises the evidence for diagnosis, screening, and treatment of gastrointestinal and hepatic diseases, and provides clear recommendations for management. A unique feature is the grading of both the evidence (randomized controlled trials, systematic reviews, or lower quality trials) and the treatment recommendations. This structure provides the reader with valuable guidance on implementation."--Provided by publisher.